Publication
TGA shelves biosimilar and generic transparency measures
In late 2020, following almost 18 months of public and industry consultations conducted by the Therapeutic Goods Administration (TGA).
Global | Publication | August 2016
The success or failure of a public offering depends on the state of the financial markets, domestic and abroad. Market conditions can change in a matter of days, sometimes even hours. Adequate preparation allowing for quick decision making can prove critical in this process. The purpose of this memorandum is to provide an overview of the factors that should be taken into account when deciding whether to go public.
While this memorandum discusses most of the material aspects of the topic at hand, it is only a brief outline of some of the issues involved. It does not contain a full analysis of the law nor does it constitute an opinion of Norton Rose Fulbright Canada LLP or any member of the firm on the points of law discussed.
Publication
In late 2020, following almost 18 months of public and industry consultations conducted by the Therapeutic Goods Administration (TGA).
Publication
The NSW Environment Protection Authority (EPA) recently released for public comment its draft Climate Change Assessment Requirements (CCARs) and draft Guide for Large Emitters (Guide).
Publication
The introduction of a minimum stockholding obligation under the Fuel Security Act 2021 (Cth) has underscored the importance of traditional liquid fuels to safeguarding Australia’s energy security as it navigates the energy transition.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023